---
title: "Jarden Reaffirms Their Buy Rating on Regis Healthcare Ltd. (REG)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284127596.md"
description: "Jarden analyst Steven Wheen has reaffirmed a Buy rating on Regis Healthcare Ltd. (REG) with a price target of A$8.50, while the shares closed at A$7.03. Wheen, a 4-star analyst, has an average return of 10.3% and a 47.15% success rate. The consensus on Regis Healthcare is a Strong Buy with an average price target of A$8.48."
datetime: "2026-04-26T23:36:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284127596.md)
  - [en](https://longbridge.com/en/news/284127596.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284127596.md)
generator: "portal-rs"
---

# Jarden Reaffirms Their Buy Rating on Regis Healthcare Ltd. (REG)

In a report released on April 23, Steven Wheen from Jarden maintained a Buy rating on Regis Healthcare Ltd., with a price target of A$8.50. The company’s shares closed last Friday at A$7.03.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Wheen is a 4-star analyst with an average return of 10.3% and a 47.15% success rate. Wheen covers the Healthcare sector, focusing on stocks such as Regis Healthcare Ltd., CSL, and Cochlear .

Currently, the analyst consensus on Regis Healthcare Ltd. is a Strong Buy with an average price target of A$8.48.

### Related Stocks

- [REG.AU](https://longbridge.com/en/quote/REG.AU.md)

## Related News & Research

- [RBC Capital downgrades Regis Healthcare Ltd. (REG) to a Hold](https://longbridge.com/en/news/297977637.md)
- [UBS Sticks to Its Hold Rating for Regis Healthcare Ltd. (REG)](https://longbridge.com/en/news/297840632.md)
- [Ord Minnett downgrades Regis Healthcare Ltd. (REG) to a Hold](https://longbridge.com/en/news/297843353.md)
- [Macquarie Keeps Their Hold Rating on Region Group (SCPAF)](https://longbridge.com/en/news/298185411.md)
- [Shaw and Partners Keeps Their Buy Rating on Polymetals Resources Ltd. (POL)](https://longbridge.com/en/news/298422932.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**